Xiaoding Xu
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery 18
- Catalysis top 2%
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 13
- MicroRNA in disease regulation 9
- Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics 25
-
- RNA Interference and Gene Delivery 38
- Advanced biosensing and bioanalysis techniques 22
- RNA modifications and cancer 11
-
- Immune cells in cancer 8
- Co-authors
- Phei Er SawOmid C. FarokhzadJacob A. MoulijnJinjun ShiWei TaoXian‐Zheng ZhangXiaoyuan JiRen‐Xi Zhuo
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Xiaoding Xu
115 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Biomaterials 1.7k
- Process Chemistry and Technology 206
- Catalysis 491
- Cancer Research 998
- Biomedical Engineering 2.3k
Countries citing papers authored by Xiaoding Xu
This map shows the geographic impact of Xiaoding Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoding Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoding Xu more than expected).
Fields of papers citing papers by Xiaoding Xu
This network shows the impact of papers produced by Xiaoding Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoding Xu. The network helps show where Xiaoding Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoding Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 16 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 20 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 8 | |
| 7 | 2021 | 22 | |
| 8 | 2021 | 59 | |
| 9 | Long Noncoding RNA CAR10 Contributes to Melanoma Progression By Suppressing miR-125b-5p to Induce RAB3D Expression | 2020 | 1 |
| 10 | 2020 | 25 | |
| 11 | 2020 | 2 | |
| 12 | 2020 | 50 | |
| 13 | 2019 | 128 | |
| 14 | 2019 | 115 | |
| 15 | 2018 | 194 | |
| 16 | 2017 | 181 | |
| 17 | 2017 | 97 | |
| 18 | 2017 | 115 | |
| 19 | Antimonene Quantum Dots: Synthesis and Application as Near‐Infrared Photothermal Agents for Effective Cancer Therapybreakdown → | 2017 | 488 |
| 20 | 2017 | 2 |
About Xiaoding Xu
Xiaoding Xu is a scholar working on Biomaterials, Cancer Research, Molecular Medicine, Molecular Biology and Catalysis, having authored 118 papers that have together received 6.5k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (38 papers), Nanoplatforms for cancer theranostics (25 papers), Advanced biosensing and bioanalysis techniques (22 papers), Nanoparticle-Based Drug Delivery (18 papers), Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (11 papers), MicroRNA in disease regulation (9 papers) and Immune cells in cancer (8 papers). The work is most often cited by research in Biomaterials (1.7k citations), Process Chemistry and Technology (206 citations), Catalysis (491 citations), Cancer Research (998 citations) and Biomedical Engineering (2.3k citations). Xiaoding Xu has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Phei Er Saw, Omid C. Farokhzad, Jacob A. Moulijn, Jinjun Shi, Wei Tao, Xian‐Zheng Zhang, Xiaoyuan Ji, Ren‐Xi Zhuo, J.J.F. Schölten and Si‐Xue Cheng. Their work appears in journals such as Nano Letters, ACS Nano, Theranostics, Angewandte Chemie International Edition and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.